中文

Sector leaders · Company list

Structural Heart Disease

Covers transcatheter aortic and mitral valves and congenital-defect occluders, a frontier medical-device chain driven by aging and rising penetration of minimally invasive valve therapy.

Why these companies

Selection basis

Representative companies are selected from 2025 growth in transcatheter valve procedures and the commercialization progress of domestic valve products. Updated 2026-09-29 · unordered list

Representative companies

Structural Heart Disease leader list

5 companies

Existing public reports are free to view. Generating a new report and professional valuation are paid features and use one credit each (2 free credits after verifying your email on sign-up).

Sources

Industry and company sources

This page is a research directory. “Representative leader” is not an official designation, a return forecast or trading advice. Valuations and reports may contain errors or outdated information; verify against company filings and authoritative sources.